171 related articles for article (PubMed ID: 30474060)
1. Triterpenoids manipulate a broad range of virus-host fusion via wrapping the HR2 domain prevalent in viral envelopes.
Si L; Meng K; Tian Z; Sun J; Li H; Zhang Z; Soloveva V; Li H; Fu G; Xia Q; Xiao S; Zhang L; Zhou D
Sci Adv; 2018 Nov; 4(11):eaau8408. PubMed ID: 30474060
[TBL] [Abstract][Full Text] [Related]
2. The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil.
Matthews JM; Young TF; Tucker SP; Mackay JP
J Virol; 2000 Jul; 74(13):5911-20. PubMed ID: 10846072
[TBL] [Abstract][Full Text] [Related]
3. Evidence for distinct mechanisms of small molecule inhibitors of filovirus entry.
Schafer A; Xiong R; Cooper L; Nowar R; Lee H; Li Y; Ramirez BE; Peet NP; Caffrey M; Thatcher GRJ; Saphire EO; Cheng H; Rong L
PLoS Pathog; 2021 Feb; 17(2):e1009312. PubMed ID: 33539432
[TBL] [Abstract][Full Text] [Related]
4. Heptad repeat 2-based peptides inhibit avian sarcoma and leukosis virus subgroup a infection and identify a fusion intermediate.
Netter RC; Amberg SM; Balliet JW; Biscone MJ; Vermeulen A; Earp LJ; White JM; Bates P
J Virol; 2004 Dec; 78(24):13430-9. PubMed ID: 15564453
[TBL] [Abstract][Full Text] [Related]
5. The fusion protein core of measles virus forms stable coiled-coil trimer.
Zhu J; Zhang CW; Qi Y; Tien P; Gao GF
Biochem Biophys Res Commun; 2002 Dec; 299(5):897-902. PubMed ID: 12470664
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the receptor-binding domain of Ebola glycoprotein in viral entry.
Wang J; Manicassamy B; Caffrey M; Rong L
Virol Sin; 2011 Jun; 26(3):156-70. PubMed ID: 21667336
[TBL] [Abstract][Full Text] [Related]
7. Six-helix bundle assembly and analysis of the central core of mumps virus fusion protein.
Liu Y; Zhu J; Feng MG; Tien P; Gao GF
Arch Biochem Biophys; 2004 Jan; 421(1):143-8. PubMed ID: 14678795
[TBL] [Abstract][Full Text] [Related]
8. Mutational analysis of the membrane proximal heptad repeat of the newcastle disease virus fusion protein.
McGinnes LW; Sergel T; Chen H; Hamo L; Schwertz S; Li D; Morrison TG
Virology; 2001 Oct; 289(2):343-52. PubMed ID: 11689056
[TBL] [Abstract][Full Text] [Related]
9. Highly specific inhibition of leukaemia virus membrane fusion by interaction of peptide antagonists with a conserved region of the coiled coil of envelope.
Lamb D; Schüttelkopf AW; van Aalten DM; Brighty DW
Retrovirology; 2008 Aug; 5():70. PubMed ID: 18680566
[TBL] [Abstract][Full Text] [Related]
10. The fusion core complex of the peste des petits ruminants virus is a six-helix bundle assembly.
Rahaman A; Srinivasan N; Shamala N; Shaila MS
Biochemistry; 2003 Feb; 42(4):922-31. PubMed ID: 12549911
[TBL] [Abstract][Full Text] [Related]
11. HIV-1 gp41 Residues Modulate CD4-Induced Conformational Changes in the Envelope Glycoprotein and Evolution of a Relaxed Conformation of gp120.
Keller PW; Morrison O; Vassell R; Weiss CD
J Virol; 2018 Aug; 92(16):. PubMed ID: 29875245
[TBL] [Abstract][Full Text] [Related]
12. Ebolavirus entry requires a compact hydrophobic fist at the tip of the fusion loop.
Gregory SM; Larsson P; Nelson EA; Kasson PM; White JM; Tamm LK
J Virol; 2014 Jun; 88(12):6636-49. PubMed ID: 24696482
[TBL] [Abstract][Full Text] [Related]
13. Design and synthesis of membrane fusion inhibitors against the feline immunodeficiency virus.
Oishi S; Kodera Y; Nishikawa H; Kamitani H; Watabe T; Ohno H; Tochikura T; Shimane K; Kodama E; Matsuoka M; Mizukoshi F; Tsujimoto H; Fujii N
Bioorg Med Chem; 2009 Jul; 17(14):4916-20. PubMed ID: 19541488
[TBL] [Abstract][Full Text] [Related]
14. Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion.
Wang E; Sun X; Qian Y; Zhao L; Tien P; Gao GF
Biochem Biophys Res Commun; 2003 Mar; 302(3):469-75. PubMed ID: 12615056
[TBL] [Abstract][Full Text] [Related]
15. Characterization of BIV Env core: implication for mechanism of BIV-mediated cell fusion.
Li S; Zhu J; Peng Y; Cui S; Wang C; Gao GF; Tien P
Biochem Biophys Res Commun; 2005 Apr; 329(2):603-9. PubMed ID: 15737628
[TBL] [Abstract][Full Text] [Related]
16. Ebola virus glycoprotein interacts with cholesterol to enhance membrane fusion and cell entry.
Lee J; Kreutzberger AJB; Odongo L; Nelson EA; Nyenhuis DA; Kiessling V; Liang B; Cafiso DS; White JM; Tamm LK
Nat Struct Mol Biol; 2021 Feb; 28(2):181-189. PubMed ID: 33462517
[TBL] [Abstract][Full Text] [Related]
17. Involvement of viral envelope GP2 in Ebola virus entry into cells expressing the macrophage galactose-type C-type lectin.
Usami K; Matsuno K; Igarashi M; Denda-Nagai K; Takada A; Irimura T
Biochem Biophys Res Commun; 2011 Apr; 407(1):74-8. PubMed ID: 21362405
[TBL] [Abstract][Full Text] [Related]
18. Identification of Ebola Virus Inhibitors Targeting GP2 Using Principles of Molecular Mimicry.
Singleton CD; Humby MS; Yi HA; Rizzo RC; Jacobs A
J Virol; 2019 Aug; 93(15):. PubMed ID: 31092576
[TBL] [Abstract][Full Text] [Related]
19. Novel Small Molecule Entry Inhibitors of Ebola Virus.
Basu A; Mills DM; Mitchell D; Ndungo E; Williams JD; Herbert AS; Dye JM; Moir DT; Chandran K; Patterson JL; Rong L; Bowlin TL
J Infect Dis; 2015 Oct; 212 Suppl 2(Suppl 2):S425-34. PubMed ID: 26206510
[TBL] [Abstract][Full Text] [Related]
20. Coronavirus escape from heptad repeat 2 (HR2)-derived peptide entry inhibition as a result of mutations in the HR1 domain of the spike fusion protein.
Bosch BJ; Rossen JW; Bartelink W; Zuurveen SJ; de Haan CA; Duquerroy S; Boucher CA; Rottier PJ
J Virol; 2008 Mar; 82(5):2580-5. PubMed ID: 18077706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
